Importance:
Synovial cell sarcoma of the head and neck (SCSHN) is a rare tumor associated with significant morbidity and mortality. The literature regarding these tumors is limited to case series and case reports. We utilized data from the population-based United States SEER cancer registry to determine factors affecting both overall survival and disease specific survival of patients with SCSHN.
Objective:
To determine the clinicopathologic and therapeutic factors determining survival in patients with SCSHN.
Design, Setting, and Participants:
The Surveillance, Epidemiology, and End Results registry was reviewed for patients with primary SCSHN from 1973–2011.
Interventions: None
Main Outcomes and Measures:
Overall survival (OS) and disease-specific survival (DSS).
Results:
A total of 167 cases of SCSHN were identified. The median age at diagnosis was 37 and 59.9% of patients were males. The mono-phasic spindle cell and biphasic variants were the most common histological subtypes. Surgical resection and radiation therapy were performed in 89.8% and 64.7% of cases, respectively. The median overall survival (OS) at 2, 5, and 10 years was 77%, 66%, and 53%, respectively. Univariate Kaplan-Meier survival analysis revealed that age, race, stage, and size were associated with improved survival. Histological subtype was not associated with significant differences in survival. Radiotherapy was associated with improved disease-specific survival (p=0.003), while surgical management was not associated with improved survival. Multivariate Cox regression analysis revealed that size >5 cm (p=0.007) and stage at presentation (p=0.003) were independent determinants of OS. When separately analyzing cohorts with tumors ≤5 cm and >5 cm, stage at presentation was found to be a significant predictor of survival in both (p=0.003, p=0.010); surgical resection and radiotherapy were not associated with differential survival outcomes using this model.
Conclusion and Relevance:
SCSHN is an extremely rare malignancy. Independent significant determinants of survival include size >5 cm and stage at presentation. Histological subtype of the tumor is not a significant predictor of survival. Surgical resection and radiation therapy were not found to be independent determinants of survival.